St. Jude Tempo pacemaker shipments under way the week of Jan. 12 following approval of Sylmar facility.
This article was originally published in The Gray Sheet
ST. JUDE TEMPO PACEMAKER SHIPMENTS UNDER WAY THE WEEK OF JAN. 12 following a build-up of inventory at the company's Pacesetter unit manufacturing facility in Sylmar, California. The firm received FDA approval for the Tempo, which incorporates "fifth generation" Minute Ventilation sensor technology, via premarket approval application supplement in August 1997, but decided to defer production until receiving an additional PMA supplement approval to manufacture at the Sylmar site Oct. 16. The systems will cost up to an average of $6,000, depending on model and purchase volume, St. Jude states.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.